| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 731.21B | 652.99B | 614.49B | 562.56B | 491.73B |
| Gross Profit | 280.87B | 249.13B | 217.04B | 190.61B | 150.02B |
| EBITDA | 185.45B | 169.85B | 147.13B | 133.61B | 101.02B |
| Net Income | 112.89B | 92.63B | 82.64B | 66.29B | 60.20B |
Balance Sheet | |||||
| Total Assets | 1.22T | 990.97B | 975.72B | 903.10B | 823.18B |
| Cash, Cash Equivalents and Short-Term Investments | 187.75B | 208.19B | 180.68B | 201.63B | 172.59B |
| Total Debt | 242.46B | 167.99B | 190.84B | 198.22B | 165.27B |
| Total Liabilities | 449.84B | 316.24B | 337.42B | 339.36B | 305.19B |
| Stockholders Equity | 767.42B | 674.57B | 637.68B | 563.67B | 514.32B |
Cash Flow | |||||
| Free Cash Flow | 72.63B | 102.83B | 85.84B | 48.68B | 47.52B |
| Operating Cash Flow | 109.38B | 132.92B | 118.18B | 69.31B | 71.91B |
| Investing Cash Flow | -165.53B | -34.25B | -91.36B | -37.38B | 11.75B |
| Financing Cash Flow | 28.62B | -71.00B | -58.24B | -1.77B | -55.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥295.11B | 8.56 | 6.37% | 2.88% | 4.27% | 24.02% | |
74 Outperform | ¥531.09B | 6.74 | 8.58% | 2.62% | 8.21% | 72.79% | |
73 Outperform | ¥1.58T | 12.10 | 13.69% | 2.65% | 11.98% | 22.34% | |
72 Outperform | ¥7.72T | 15.56 | 8.97% | 1.38% | 6.56% | 38.17% | |
68 Neutral | ¥5.22T | 7.75 | 6.98% | 2.98% | 5.28% | 12.66% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥1.79T | 6.16 | 8.34% | 2.03% | 4.53% | 65.12% |